At a recent Society for Neuroscience meeting, researchers reported that during a pilot study for a drug used to treat leukemia, 11 out of 12 patients who were given a small dose had improvement in mental function and movement. For several of the patients, improvements were dramatic.
“After 25 years in Parkinson’s disease research, this is the most excited I’ve ever been” says Fernando Pagan, director of the Movement Disorders Program at Georgetown University Medical Center. Learn more about the study here >> http://www.npr.org/sections/health-shots/2015/10/17/448323916/can-a-cancer-drug-reverse-parkinsons-disease-and-dementia
